Equine CA199 antibody and antigen (recombinant protein)
Diagnostic anti-Equine CA199 antibodies pairs and antigen for animal health (animal Equine/Horse pancreatic and biliary tract tumors) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to pancreatic and biliary
tract tumors diagnostics products collection
>>
Product information
Size: 1mg | 10mg | 100mg
Catalog No. | Description | US $ Price (per mg) | First Order Discount | First Order Discount Price |
---|---|---|---|---|
GMP-EQU-CA199-Ag01 | Recombinant Equine CA199 protein | 3090 | ||
GMP-EQU-CA199-Ab01 | Anti-Equine CA199 mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
GMP-EQU-CA199-Ab02 | Anti-Equine CA199 mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
GMP-EQU-CA199-Ab03 | Anti-Equine CA199 mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
GMP-EQU-CA199-Ab04 | Anti-Equine CA199 mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)
Product Description
Cat No. of Products | GMP-EQU-CA199-Ag01 |
Product Name | Recombinant Equine CA199 protein |
Target/Biomarker | Equine Carbohydrate antigen 19-9 (CA199) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine Carbohydrate antigen 19-9 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA199 level test of animal Equine/Horse with pancreatic and biliary tract tumors. |
Tag | His |
Products description | Recombinant Equine CA199 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-CA199-Ab01, GMP-EQU-CA199-Ab02, GMP-EQU-CA199-Ab03, GMP-EQU-CA199-Ab04 |
Product Name | Anti-Equine CA199 mouse monoclonal antibody (mAb) |
Target/Biomarker | Equine Carbohydrate antigen 19-9 (CA199) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Anti-Equine Carbohydrate antigen 19-9 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA199 level test of animal Equine/Horse with pancreatic and biliary tract tumors. |
Tag | mFc |
Products description | Anti-Equine CA199 mouse monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Cancer Antigen 199 (CA199) is a glycoprotein biomarker with vital implications in equine health, particularly in the sphere of cancer diagnosis and monitoring. This biomarker is associated with several types of cancer in horses, including those affecting the gastrointestinal tract and pancreas. Structurally, CA199 is classified as a carbohydrate antigen, featuring a protein core with attached carbohydrate molecules. In the context of equine health, CA199 assumes significance as a diagnostic tool for the early detection of cancer. Cancers affecting the gastrointestinal and pancreatic regions can be insidious, often presenting with subtle or nonspecific clinical signs. CA199 blood tests offer a non-invasive and highly sensitive means of identifying these malignancies, enabling prompt intervention and potentially improving treatment outcomes. CA199 levels in a horse's bloodstream become elevated when cancer cells, particularly those found in the gastrointestinal and pancreatic cancers, produce and release this glycoprotein. As a result, CA199 serves as a biomarker that can be readily detected and quantified through blood tests.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.